Table 4 Outcomes and covariates
Demographics o Patient age o Patent birth year o Patient gender o Patient ethnicity coding o Weight o Height o Body mass index | Outcome measures o 90-day post-operative complications (Clavien-Dindo classification (18)) o Disease outcomes including 30-day survival o Death / recurrence / disease-free survival o Patient compliance diary data o Device usage |
Disease o ASA grade (American College of Anaesthesiology) physical status o Past medical history (other or previous illnesses and surgery) | Body composition parameters o CT body composition at the level of the L3 vertebra o Bio-impedance analysis o Anthropometric measurements |
Cancer-specific characteristics o Type of cancer (primary/recurrent cancer, location and subtype on histology) o Grade of cancer o Stage of cancer | Inflammatory markers o Serum C-reactive protein o White cell count o Serum albumin o Platelet count |
Treatment factors o Details of surgery o Chemotherapy o Radiotherapy | Patient-specific and functional outcomes o Quality of life - ED-5Q-5L - EORTC QLQ – CR29 o Patient satisfaction |